INTRODUCTION
The functional specialization of the mammalian liver is dictated by specific regulation of gene transcription in the terminally differentiated hepatocyte [1] . Studies with cultured hepatoma cell lines have revealed that expression of many of the genes of hepatic carbohydrate metabolism is regulated in a complex manner by hormones such as glucagon, via its second messenger cyclic AMP (cAMP), glucocorticoids and insulin [2, 3] . The effects of hormones on gene expression in hepatoma cells or primary hepatocytes are, in general, consonant with their established physiological actions: insulin increases the abundance ofmRNAs that encode glycolytic enzymes [e.g. glucokinase, pyruvate kinase, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase)] and decreases mRNAs that encode gluconeogenic enzymes [e.g. phosphoenolpyruvate carboxykinase (PEPCK) and fructose-1,6-bisphosphatase (Fru-1,6-P2ase)]; cAMP has the opposite effects. Glucocorticoid hormones, on the other hand, have a more limited action, playing an important role in increasing PEPCK and 6PF-2-K/Fru-2,6-P2ase mRNA abundances, and they also have a permissive action in the regulation of pyruvate kinase mRNA by insulin [2, 3] . However, while the cis/trans model of gene regulation has been successfully applied to an analysis of the PEPCK gene promoter in hepatoma cells, this approach has yielded only limited success with promoters for other genes, such as those for pyruvate kinase, glucokinase and 6PF-2-K/Fru-2,6-P2ase [2, 3] . The [2, 3] for a review), does not occur in hepatoma cells [4] , and which is similar to that observed in rat liver. In contrast, in another rat hepatoma cell line, FTO-2B, only the skeletal muscle mRNA was detected. Insulin and dexamethasone induced the liver bifunctional enzyme mRNA in FAO-I cells by 2-4-fold and 10-20-fold respectively in a concentration-and time-dependent manner, and their effects were antagonized by cyclic AMP. Transcription of the gene in FAO-I cells, measured by nuclear run-on assays, was also enhanced by dexamethasone and insulin. It is concluded that the FAO-I cell line is similar to liver with respect to both the preferential use of the liver promoter of the gene and its regulation by hormones, and is therefore an excellent model for the study of the hepatic expression of this gene.
can only be studied in primary hepatocytes [5] . However, with the exception of PEPCK, none of the liver-specific forms of glycolytic and gluconeogenic enzymes are expressed in primary hepatocyte cultures unless insulin and/or dexamethasone are added to the media. Furthermore, primary hepatocyte cultures present many technical problems, including reproducibility and survival time.
The bifunctional enzyme 6PF-2-K/Fru-2,6-P2ase catalyses the synthesis and hydrolysis of fructose 2,6-bisphosphate (Fru-2,6-P2), a potent modulator of both glycolysis and gluconeogenesis, through its action on the activities of 6-phosphofructo- 1- kinase (6PF-l-K) and Fru-1 ,6-P2ase [6, 7] . 6PF-2-K/Fru-2,6-P2ase is expressed in all mammalian tissues [8, 9] . The liver and skeletal muscle isoforms are different with respect to their Nterminal sequences, phosphorylation/dephosphorylation reactions and patterns of regulation by metabolites [7] [8] [9] . Both isoforms are products of a single 55 kb gene which contains 15 exons [10, 11] , with the muscle-specific transcript being initiated just distal to an upstream promoter containing exon 1M and from which the liver exon 1L is spliced out during processing. The liver-specific transcript is initiated just distal to a second promoter, upstream of exon 1L, and generates exon 1L. Either of these first exons (1L or 1M) is then spliced to the common exons 2-14. Cell-specific regulation of the liver and skeletal muscle forms of the enzyme is thus accomplished by the alternative first exons providing unique mRNAs in these tissues [2, 3] .
Both insulin and dexamethasone enhance bifunctional enzyme gene transcription in the rat hepatc.ma cell line FTO-2B [12] , although the mRNA expressed was shown to be related to the skeletal muscle transcript. This finding raises doubt as to whether the same hormone response elements in the gene are involved in the regulation of the liver-specific mRNA that has been observed Abbreviations used: cAMP, cyclic AMP; PEPCK, phosphoenolpyruvate carboxykinase; 6PF-1-K, 6-phosphofructo-1-kinase; 6PF-2-K/Fru-2,6-P2ase, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; Fru-1,6-P2ase, fructose-1,6-bisphosphatase; Fru-2,6-P2, fructose 2,6-bisphosphate; Fru-6-P, [2, 3] . In order to develop a cell culture model more suitable for studying regulation of the liver mRNA, we screened a number of rat hepatoma cell lines in an attempt to find a line that has a pattern of 6PF-2-K/Fru-2,6-P2ase gene expression and hormonal regulation similar to that found in rat liver in vivo. In this paper we report that FAO-i cells meet these criteria.
MATERIALS AND METHODS Materials
The random-primed DNA labelling kit, restriction endonucleases, nucleotides, bovine insulin and dibutyryl cAMP were purchased from Boehringer Mannheim. [ 
Cell culture
Monolayer cultures of rat FAO-1 hepatoma-derived cells were grown in RPMI 1640 medium containing 10 mM glucose and supplemented with 10 % fetal bovine serum. FTO-2B cells were maintained in culture as described previously [12] . All experiments were carried out before the cell density reached confluency and cells were incubated in serum-free medium during the hormonal treatment. Hormone effects were tested in the absence of serum to ensure that trace hormone concentrations in serum would not confound the results. The results are presented relative to untreated controls, incubated in the absence ofserum, analysed at the same time as the treated cells. Since the cells were cultured in serum until confluency and then without serum for the duration of the experiment, it is possible that the basal level of expression changed during the experiment. In order to test whether the absence of serum in itself had any effect, cells were incubated with and without serum for up to Measurement of 6PF-2-K/Fru-2,6-P2ase activity FAO-1 cells (-4 x 107) were homogenized in medium composed of 100 mM KC1, 20 mM Tes, pH 7.8, 5 mM potassium phosphate, 5 mM EDTA, 5 mM EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethanesulphonyl fluoride and 2.5 mg/l leupeptin. The enzyme was partially purified by a 6-21 % poly-(ethylene glycol) 8000 precipitation [13] . Under these conditions the in situ phosphorylation state of the enzyme is preserved [13] . 6PF-2-K activity was assayed by measuring the rate of Fru-2,6-P2 production from fructose 6-phosphate (Fru-6-P) and MgATP at pH 7.8 [13, 14] . Fru-2,6-P2 was assayed by its ability to activate pyrophosphate-dependent 6PF-1-K from potato tubers (Sigma) [15] . Fru-2,6-P2ase activity was assayed by measuring [32P]P1 release from [2-32P] Fru-2,6-P2 (10 ,uM) [14] or by phosphoenzyme formation [14, 16] . [20] . 
RNA Isolation and analysis
RNA was isolated essentially according to Chirgwin et al. [21] , with one extraction in 4 M guanidine thiocyanate followed by two successive extractions with 7.5 M guanidine hydrochloride.
The abundance of the mRNA for 6-PF-2-K/Fru-2,6-P2ase was determined either by Northern blot analysis [22] or by RNAase protection assay [23] . In both cases densitometric scans of the autoradiograms were carried out on an LKB-Pharmacia UltroScan XL Laser Densitometer. .mp 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene regulation
Ribonuclease protection assay
An RNA probe was constructed according to Maniatis et al. [23] . The 0.5 kb EcoRI fragment, previously described [13] , was cloned into the EcoRI restriction site of the plasmid Bluescript SK(+). The plasmid was linearized by digestion with Avall, and was then used to synthesize RNA using its T3 RNA polymerase promoter, with ribonucleotide triphosphates, including [a-32P]-CTP, and T3 RNA polymerase. The synthesized riboprobe was 390 bases long, complementary to 319 bases of the liverspecific mRNA, including exon 1,L and to 192 bases of the skeletal muscle-specific mRNA. The probe was purified by electrophoresis in 60% polyacrylamide, in the presence of 8 M urea and Tris/borate/EDTA buffer. Samples of 10-50 ,g of total RNA from extracts of nearly confluent cells, and from rat liver and rat muscle, were incubated at 90°C for 10 min with a molar excess (100000 c.p.m.) of the purified riboprobe. The tubes were cooled slowly to 42°C, and maintained at this temperature overnight. The assay was performed as described by Hod [24] . A mixture of RNAase TI and RNAase A were used to degrade single-stranded unhybridized probe. After digestion, the protected fragments were collected by centrifugation (12000 g; 15 min) at 4°C in the presence of guanidine thiocyanate and propan-2-ol, and subjected to electrophoresis on DNA sequencing gels, as described previously [24] . The gels were then subjected to autoradiography and densitometric scanning.
Measurement of run-on gene transcription in Isolated nuclei
The isolation of nuclei and the incorporation of [a-32P]UTP into nascent RNA transcripts of 6PF-2-K/Fru-2,6-P2ase were performed as previously described [12] .
cDNA library construction"and screening A cDNA library was constructed by using mRNA isolated from FAO-I cell extracts, a cDNA synthesis kit from Pharmacia, and a A ZAP II cloning kit from Stratagene. In order to obtain the 5' region of the 6PF-2-K/Fru-2,6-P2ase gene, four different specific oligonucleotides, located in the common region of the gene, were used to prime the reverse transcriptase reaction. The library was screened with the 0.5 kb EcoRI cDNA probe [13] . Positive clones were excised in vivo with R408 helper phage.
DNA sequencing and analysis
All sequencing was done by the Sanger dideoxy method [25] using the Sequenase sequencing kit (U.S. Biochemicals, San Diego, CA, U.S.A.). Sequence analysis was carried out using the GCG software package [26] .
Protein determination
Protein concentration was determined with the BCA Protein Assay Reagent from Pierce Chemical Co., using the enhanced protocol and with BSA as a standard.
RESULTS
Expression of 6PF-2-KIFru-2, that had a molecular mass of 55 kDa, which is identical to the size of the 6PF-2-K/Fru-2,6-P2ase subunit from rat liver (results not shown). As with 6PF-2-K activity, a quantitatively similar enhancement in Fru-2,6-P2ase activity was observed in cells treated with insulin or dexamethasone. The activity ratio of kinase to bisphosphatase was about 1.4, which is similar to that for the liver enzyme, but different from the activity ratios of 0.1-0.5 and 50 found in skeletal muscle and heart respectively [8] .
The 6PF-2-K activity in livers from normal fed rats is approx. 40 ,units/mg of cellular protein [13] . More conclusive results were obtained by an RNAase protection assay (Figure 2) . Use of the 390-base RNA probe permitted a clear discrimination between the liver and muscle mRNAs ( Figure 2 ). As predicted, the major protected fragment in liver RNA was 319 bases long, corresponding to the region complementary to the liver mRNA, while the major protected fragment in skeletal muscle RNA was 192 bases long. No protected bands were observed with yeast RNA. While liver and skeletal muscle contained both the liver and skeletal muscle transcripts, their abundances are clearly different in the two tissues: in liver the liver transcript is the predominant form, while in skeletal muscle the reverse is true. Quantification revealed that the liver mRNA constituted approx. 15% of the total bifunctional mRNA in skeletal muscle, while the skeletal muscle mRNA accounted for only about 10 % of the total bifunctional mRNA in liver (Table 1 ). This result shows that both mRNAs from rat liver. Application of the RNAase protection assay to RNA from FAO-i cells showed a pattern of tissue-specific expression that is identical to that of rat liver (Figure 2b ; Table  1 ), albeit at one-fifth the abundance. This is in contrast to enzyme activity levels, which are about two-thirds of those in liver. The explanation for this discrepancy is not clear, but may relate to different rates of translation and/or protein degradation in the FAO-I cells versus the liver. Figure 2(c) shows that only the skeletal muscle mRNA is expressed in another rat hepatoma cell line, FTO-2B, a finding consistent with earlier studies of FTO-2B cell 6PF-2-K/Fru-2,6-P2ase mRNA, which was recognized by a skeletal muscle-specific cDNA probe but not by a liver-specific probe [12] . Table 1 shows that the abundance of skeletal muscle mRNA in FTO-2B cells is slightly greater than that of the skeletal muscle mRNA in rat liver.
In order to rule out a possible dissimilarity in the sequences of the 5' ends of the liver and FAO-I cell mRNAs, an FAO-I cDNA library was screened as described in the Materials and methods section, and a clone containing the 5' end of the 6PF-2-K/Fru-2,6-P2ase gene was isolated. Its sequence was identical to that of the first 328 bases of the liver 6PF-2-K/Fru-2,6-P2ase cDNA (results not shown). This finding supports the hypothesis that the predominant FAO-I cell bifunctional enzyme mRNA is identical to the liver-specific mRNA.
Hormonal control of 6PF-2-K/Fru-2,6-P2ase gene expression in FAO cells of the response to dexamethasone was seen as early as 3 h, suggesting that the mechanism of induction of 6PF-2-K/Fru-2,6-P,ase mRNA may differ for the two hormones.
As can be seen in Figure 4 (a), 0.1 ,uM insulin was sufficient to increase the 6PF-2-K/Fru-2,6-P2ase mRNA abundance (lane 2), although a much larger increase was observed in the presence of dexamethasone (lanes 4, 5 and 6). As expected, the content of PEPCK mRNA in FAO-I cells was increased by dexamethasone and cAMP (Figure 4b, lanes 4-6, and 7 and 8, respectively) . Dibutyryl cAMP plus theophylline, in the absence of insulin or dexamethasone, had no effect on 6PF-2-K/Fru-2,6-P2ase mRNA abundance. Dibutyryl cAMP Inhibits the induction of 6PF-2-K/Fru-2,6-P2ase mRNA by insulin and dexamethasone Induction of 6PF-2-K/Fru-2,6-P2ase mRNA by either insulin or dexamethasone was counteracted by the simultaneous addition of cAMP analogues to the incubation medium ( Figure 6 ). Monobutyryl cAMP was sufficient to counteract the insulin induction of the gene, whereas the presence of both theophylline and dibutyryl cAMP were required to antagonize the much more potent effect of dexamethasone. The cAMP analogues repressed the effect of saturating concentrations of dexamethasone and insulin, suggesting that they play a dominant role in regulating this gene's expression in FAO-I cells. A similar dominant role of cAMP in affecting the induction of the skeletal muscle bifunctional enzyme mRNA has been reported for FTO-2B cells [12] .
Induction of 6PF-2-K/Fru-2,6-P2ase mRNA is mediated by activation of gene transcription
The increase in mRNA may be explained by an increase in its rate of synthesis, by a decrease in its degradation rate, or by a combination of both mechanisms. relative transcription rate of the gene in cells exposed to either insulin or dexamethasone for 9 h. The time courses of induction of 6PF-2-K/Fru-2,6-PJase gene transcription and mRNA abundance ( Figure 3) showed that the rate of mRNA accumulation generally followed the changes in the relative synthesis rate of the mRNA (results not shown). These results strongly suggest that the mechanism for the increase in the 6PF-2-K/Fru-2,6-P2ase mRNA level in cells exposed to insulin or dexamethasone is mediated, in large part by stimulation of the transcription rate of the gene. For comparison, the transcriptional activity of the gene coding for PEPCK was also analysed in the same experiment ( Figure 7b ). As expected, the transcription of the PEPCK gene was enhanced in cells treated with dexamethasone and inhibited in cells incubated in the presence of insulin. The relatively small effects of insulin and dexamethasone on PEPCK transcription relate to the fact that measurements were done after 9 h. A similar extent of inhibition by insulin of PEPCK gene transcription has been documented previously [28] . The differential response in the relative transcription rates of the 6PF-2-K/Fru-2,6-P2ase and PEPCK genes in response to insulin and dexamethasone indicates that the enhancement in the transcription rate of 6PF-2-K/Fru-2,6-P2ase gene is specific.
DISCUSSION
Studies on the control of skeletal muscle/liver 6PF-2-K/Fru-2,6-P2ase gene expression have been done in vivo and in rat hepatoma FTO-2B cells. The amount of bifunctional enzyme protein decreases in livers of rats during starvation or diabetes, and is restored by refeeding a high-carbohydrate diet or by insulin administration respectively [13, 29] . The amount of 6PF-2-K/Fru-2,6-P2ase mRNA is also reduced in liver and skeletal muscle of adrenalectomized rats, and is restored by administration of glucocorticoids which increase gene transcription [11, 17, 27] . This is a direct effect of glucocorticoids, since their addition to primary cultures of hepatocytes rapidly increases mRNA levels by nearly 100-fold [17] . [27] . Furthermore, although only the skeletal muscle transcript is expressed in FTO-2B cells, regulation of this transcript by insulin, dexamethasone and cAMP is similar to that observed for the liver-specific transcript in vivo and in primary cultures of hepatocytes [31] , except that dexamethasone is a more potent inducer of 6PF-2-K/Fru-2,6-P2ase gene expression than insulin in vivo [13, 29] , in primary hepatocyte cultures [31] and in FAO-i cells (present paper), but the reverse is true in FTO-2B cells [12] . The reason for this difference in hormone responsiveness is not known. Analysis of RNA isolated from rat hepatoma H35 cells, from which both FTO-2B and FAO-i cells were derived [32] , also revealed a pattern of bifunctional enzyme gene expression that is similar to those of FAO-i cells and rat liver (A. Vargas, unpublished work). Since FTO-2B cells were originally generated by treating a derivative cell line of H35 cells with mutagens and visible light in order to select for thymidine kinase-deficient cells [33] , it is possible that this treatment and/or subsequent selective pressures on the cell line have resulted in an apparent loss of liver-specific factors that activate the liver promoter.
The finding that bifunctional enzyme gene expression is subject to regulation by the same set of hormones in FAO-I and FTO-2B cells suggests that the same hormone response elements act on both promoters. Consistent with this idea, a unique glucocorticoid response unit, recently identified in the first intron of the gene, has been shown to enhance the activity of both promoters in transiently transfected cells [II] . This finding, and the results of LeMaigre et al. [34] and Darville et al. [35] , argue strongly for the existence of two separate functional promoters of the gene. Based on the results presented here, it is reasonable to postulate the existence of tissue-specific regulatory systems which determine the relative activities of the liver and skeletal muscle promoters in their respective tissues. Previous work has demonstrated the presence of numerous binding sites for transacting factors in the 5'-flanking regions of the gene that influence the activities of both the liver and skeletal muscle promoters [34, 35] . However, tissue-specific transcriptional factors responalso induce bifunctional enzyme mRNA in FTO-2B cells, but these cells express a skeletal muscle 6PF-2-K/Fru-2,6-P2ase 
